share_log

EQRX INC C/WTS (TO PUR COM) | 8-K: EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results

SEC announcement ·  May 8, 2023 16:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more